These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2793733)

  • 1. Contact phase of blood coagulation is not activated in edema of high altitude.
    Bärtsch P; Lämmle B; Huber I; Haeberli A; Vock P; Oelz O; Straub PW
    J Appl Physiol (1985); 1989 Oct; 67(4):1336-40. PubMed ID: 2793733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].
    Damas J; Adam A
    Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
    Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH
    Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
    Schmaier AH; Farber A; Schein R; Sprung C
    J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
    Chan JY; Movat HZ; Burrowes CE
    Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
    Revak SD; Cochrane CG; Bouma BN; Griffin JH
    J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemofiltration removes bradykinin generated in the priming blood in cardiopulmonary bypass during circulation.
    Sakurai H; Maeda M; Murase M; Koyama T; Hayakawa M
    Ann Thorac Cardiovasc Surg; 1998 Apr; 4(2):59-63. PubMed ID: 9576999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the participation of the contact system in the Vroman effect. Review and summary.
    Scott CF
    J Biomater Sci Polym Ed; 1991; 2(3):173-81. PubMed ID: 1854683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.